Avalon Ventures and COI Pharmaceuticals Announce Acquisition of Sitari Pharmaceuticals by GSK

SAN DIEGO–(BUSINESS WIRE)–#SanDiego–GSK to acquire Sitari Pharmaceuticals, which has been developing a transglutaminase 2 small molecule program for the treatment of celiac disease.

Click to view original post